Your browser doesn't support javascript.
Incidence of COVID-19 in a cohort of dermatology patients receiving immunomodulating biologic medications.
Alamgir, Mahin; Jamgochian, Marielle; Cucalon, Jennifer; Razi, Shazli; Farabi, Banu; Rao, Babar.
  • Alamgir M; Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, NJ, USA.
  • Jamgochian M; Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, NJ, USA.
  • Cucalon J; St George's University School of Medicine, Grenada, Dominica.
  • Razi S; Rao Dermatology, New York, NY, USA.
  • Farabi B; Department of Internal Medicine, St Peter's University Hospital, New Brunswick, NJ, USA.
  • Rao B; Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, NJ, USA.
Int J Dermatol ; 60(12): e500-e501, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1443276

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biological Products / Dermatology / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Int J Dermatol Year: 2021 Document Type: Article Affiliation country: Ijd.15922

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Biological Products / Dermatology / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Int J Dermatol Year: 2021 Document Type: Article Affiliation country: Ijd.15922